Skip to main
AMLX
AMLX logo

Amylyx Pharmaceuticals (AMLX) Market Capitalization Overview

Market Cap: $561.59M as of Jul 3, 2025

$561.59M
Past Month+$123.02M (28.05%)
As of Jul 3, 2025, Amylyx Pharmaceuticals (AMLX) has a market capitalization of $561.59M. Over the past 30 days, its market cap has increased by 25.69%, while in the last 12 months, it has increased by 116.74%.

Market capitalization represents the total value of Amylyx Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Amylyx Pharmaceuticals (AMLX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Amylyx Pharmaceuticals (AMLX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Amylyx Pharmaceuticals (AMLX) Market Cap History

DateMarket CapChange
Jul 1, 2025$571.40M+25.69%
Jun 2, 2025$454.62M-0.71%
May 1, 2025$457.90M+54.73%
Apr 1, 2025$295.94M+15.12%
Mar 3, 2025$257.08M+9.66%
Feb 3, 2025$234.44M-12.53%
Jan 2, 2025$268.03M-29.55%

Amylyx Pharmaceuticals (AMLX) End of Year Market Cap History

DateMarket CapChange
2025$561.59M+116.74%
2024$259.12M-73.92%
2023$993.68M-54.06%
2022$2.17B

FAQs About Amylyx Pharmaceuticals (AMLX) Market Cap

As of Jul 3, 2025, the market capitalization of Amylyx Pharmaceuticals (AMLX) is $561.59M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Amylyx Pharmaceuticals’s market capitalization has increased by 28.05%, changing from $438.58M to $561.59M as of Jul 3, 2025.

In the last 3 months, Amylyx Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Amylyx Pharmaceuticals’s market capitalization decreased from $993.68M in January to $259.12M in December, reflecting a -73.92% change.

In the past five years, Amylyx Pharmaceuticals (AMLX) has had a compound annual growth rate (CAGR) of -50.70% in market capitalization. This means its market cap has shrunk at an average rate of -50.70% per year.

Amylyx Pharmaceuticals (AMLX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.